Lingzhi Yan
Lingzhi Yan
Suzhou, Jiangsu, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients | Newly Diagnosed Multiple Myeloma | Recruiting | Not stated | 2024-11-12 | NCT06682156 |